Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole Rotmensz

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Breast (Edinburgh, Scotland)|February 14, 2006
Rethinking TNM: breast cancer TNM classification for treatment decision-making and researchUmberto Veronesi, Giuseppe Viale, Nicole Rotmensz, et al.
Journal of the National Cancer Institute|July 22, 2004
Re: Trends in the treatment of ductal carcinoma in situ of the breastMattia Intra, Nicole Rotmensz, Giuseppe Viale, et al.
Clinical Breast Cancer|August 14, 2010
Axillary lymph node involvement in women with breast cancer: does it depend on age?Edoardo Botteri, Vincenzo Bagnardi, Aaron Goldhirsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2009
Breast cancer classification: time for a changeUmberto Veronesi, Stefano Zurrida, Aron Goldhirsch, et al.
Plastic and Reconstructive Surgery|May 25, 2017
Fat Grafting after Invasive Breast Cancer: A Matched Case-Control StudyJean Yves Petit, Patrick Maisonneuve, Nicole Rotmensz, et al.
Surgical Oncology|December 24, 2004
Sentinel node biopsy in elderly breast cancer patientsRoberto Gennari, Nicole Rotmensz, Elisa Perego, et al.
International Journal of Cancer|February 27, 2016
Use of beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and breast cancer survival: Systematic review and meta-analysisSara Raimondi, Edoardo Botteri, Elisabetta Munzone, et al.
European Journal of Cancer (Oxford, England : 1990)|November 21, 2017
Prognostic value of tumour-infiltrating lymphocytes in small HER2-positive breast cancerCarmen Criscitiello, Vincenzo Bagnardi, Giancarlo Pruneri, et al.
Anticancer Research|June 30, 2016
HER2 Equivocal Status in Early Breast Cancer Is Not Associated with Higher Risk of RecurrenceCarmen Criscitiello, Vincenzo Bagnardi, Giuseppe Viale, et al.
Trials|July 29, 2008
Approaches to interim analysis of cancer randomised clinical trials with time to event endpoints: a survey from the Italian National Monitoring Centre for Clinical TrialsIrene Floriani, Nicole Rotmensz, Elena Albertazzi, et al.
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Breast (Edinburgh, Scotland)|February 14, 2006
Rethinking TNM: breast cancer TNM classification for treatment decision-making and researchUmberto Veronesi, Giuseppe Viale, Nicole Rotmensz, et al.
Journal of the National Cancer Institute|July 22, 2004
Re: Trends in the treatment of ductal carcinoma in situ of the breastMattia Intra, Nicole Rotmensz, Giuseppe Viale, et al.
Clinical Breast Cancer|August 14, 2010
Axillary lymph node involvement in women with breast cancer: does it depend on age?Edoardo Botteri, Vincenzo Bagnardi, Aaron Goldhirsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2009
Breast cancer classification: time for a changeUmberto Veronesi, Stefano Zurrida, Aron Goldhirsch, et al.
Plastic and Reconstructive Surgery|May 25, 2017
Fat Grafting after Invasive Breast Cancer: A Matched Case-Control StudyJean Yves Petit, Patrick Maisonneuve, Nicole Rotmensz, et al.
Surgical Oncology|December 24, 2004
Sentinel node biopsy in elderly breast cancer patientsRoberto Gennari, Nicole Rotmensz, Elisa Perego, et al.
International Journal of Cancer|February 27, 2016
Use of beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and breast cancer survival: Systematic review and meta-analysisSara Raimondi, Edoardo Botteri, Elisabetta Munzone, et al.
European Journal of Cancer (Oxford, England : 1990)|November 21, 2017
Prognostic value of tumour-infiltrating lymphocytes in small HER2-positive breast cancerCarmen Criscitiello, Vincenzo Bagnardi, Giancarlo Pruneri, et al.
Anticancer Research|June 30, 2016
HER2 Equivocal Status in Early Breast Cancer Is Not Associated with Higher Risk of RecurrenceCarmen Criscitiello, Vincenzo Bagnardi, Giuseppe Viale, et al.
Trials|July 29, 2008
Approaches to interim analysis of cancer randomised clinical trials with time to event endpoints: a survey from the Italian National Monitoring Centre for Clinical TrialsIrene Floriani, Nicole Rotmensz, Elena Albertazzi, et al.
Pageof 13